Endoscopic ultrasound gastroenterostomy vs duodenal stenting for malignant gastric outlet obstruction: Cost-effectiveness study
Endoscopy International Open · 12.03.2025 · 13 (CP)
DOI: 10.1055/a-2509-7671 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy International Open, erschienen am 12.03.2025. Verfasst von Daryl Ramai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Boston, United States. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Enteral stenting has been traditionally employed for managing malignant gastric outlet obstruction (GOO). However, concerns regarding high reintervention rates have brought into question its cost-effectiveness. Endoscopic ultrasound–guided gastroenterostomy (EUS-GE) with a lumen-apposing metal stent (LAMS) provides an alternative to luminal stenting. The goal of this study was to assess the cost-effectiveness of EUS-GE relative to duodenal stenting. A decision analysis was performed to analyze costs and survival in patients with unresectable or metastatic GOO. The model was designed with two treatment arms: self-expanding metal stent (SEMS) placement and EUS-GE with LAMS. Costs were derived from Medicare reimbursement rates (US$) while effectiveness was measured by quality-adjusted life years (QALYs). The primary outcome measure was the incremental cost-effectiveness ratio (ICER). Probabilistic sensitivity analyses were performed. Endoscopic stenting resulted in an average cost of $22,748 and 0.31 QALYs whereas EUS-GE cost $32,254 and yielded 0.53 QALYs, which yielded a difference of $9,507 in cost and 0.23 in QALY. EUS-GE was found to be a cost-effective strategy over duodenal stenting (ICER, $41994/QALY) at a willingness-to-pay of $100,000/QALY. In 10,000 Monte-Carlo simulations, EUS-GE was favored 62% of the time. Using a tornado diagram, the model was most sensitive to the probability of mortality in patients with duodenal stents compared with EUS-GE. In patients with malignant GOO, EUS-GE is a cost-effective palliative intervention compared with duodenal stenting.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Boston, United States.
- Division of Epidemiology, University of Utah Health, Salt Lake City, United States.
- VA Salt Lake City Medical Center, IDEAS Center, Salt Lake City, United States.
- Department of pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, United States.
- Gastroenterology and Hepatology, University of Cincinnati, Cincinnati, United States.
- Gastroenterology, University of Utah Health, Salt Lake City, United States.
Zitieren
APA
Ramai, D., Nelson, R., Chaiyakunapruk, N., Ofosu, A., & Fang, J. C. (2025). Endoscopic ultrasound gastroenterostomy vs duodenal stenting for malignant gastric outlet obstruction: Cost-effectiveness study. Endoscopy International Open, 13(CP). https://doi.org/10.1055/a-2509-7671
Vancouver
Ramai D, Nelson R, Chaiyakunapruk N, Ofosu A, Fang JC. Endoscopic ultrasound gastroenterostomy vs duodenal stenting for malignant gastric outlet obstruction: Cost-effectiveness study. Endoscopy International Open. 2025;13(CP). doi:10.1055/a-2509-7671
BibTeX
@article{Ramai2025,
author = {Ramai, Daryl and Nelson, Richard and Chaiyakunapruk, Nathorn and Ofosu, Andrew and Fang, John C},
title = {Endoscopic ultrasound gastroenterostomy vs duodenal stenting for malignant gastric outlet obstruction: Cost-effectiveness study},
journal = {Endoscopy International Open},
year = {2025},
volume = {13},
number = {CP},
doi = {10.1055/a-2509-7671}
}
EUVIMED